Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID Prevention Transcript

Operator

Good day and thanks for standing by. Welcome to the Invivyd REVOLUTION Pivotal Program Convention Name. [Operator Instructions] Please be suggested that at this time’s convention is being recorded. I might now like handy the convention over to your first speaker at this time, Katie Falzone, Senior Vice President of Finance. Please go forward.

Katie Falzone

Thanks, operator, and thanks for becoming a member of at this time’s webcast. The slides which are getting used on at this time’s webcast might be made out there inside the Buyers part of the Invivyd web site beneath the Occasions and Displays part shortly after at this time’s name. At this time’s dialogue might be led by Marc Elia, Chairman of Invivyd’s Board of Administrators; he’s joined by Dr. Robert Allen, Chief Scientific Officer; Dr. Mark Wingertzahn, Senior Vice President of Scientific Improvement; and Tim Lee, Chief Business Officer. As famous by the operator, there might be a question-and-answer session on the conclusion of at this time’s name.

Throughout at this time’s dialogue, we might be making forward-looking statements regarding, amongst different issues, our analysis and improvement actions, our regulatory plans, our company and business technique, our future prospects and different statements that aren’t historic information. These forward-looking statements are lined inside the that means of the Personal Securities Litigation Reform Act and are topic to numerous dangers, assumptions and uncertainties which will change over time and trigger our precise outcomes to vary materially from these expressed or